Cargando…

CDK10 functions as a tumor suppressor gene and regulates survivability of biliary tract cancer cells

Cyclin-dependent kinase 10 (CDK10) is a member of the Cdc2 family of kinases, and has been demonstrated to be an important determinant of resistance to endocrine therapy for breast cancer. To investigate the expression and possible function of CDK10 in biliary tract cancer (BTC), we systematically e...

Descripción completa

Detalles Bibliográficos
Autores principales:	YU, JIAN-HUA, ZHONG, XIANG-YU, ZHANG, WEI-GUANG, WANG, ZHI-DONG, DONG, QIN, TAI, SHENG, LI, HUI, CUI, YUN-FU
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2011
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583593/ https://www.ncbi.nlm.nih.gov/pubmed/22209942 http://dx.doi.org/10.3892/or.2011.1617

Ejemplares similares

A nomogram to predict overall survival for biliary tract cancer
por: Song, Wei, et al.
Publicado: (2018)

CDK10 in Gastrointestinal Cancers: Dual Roles as a Tumor Suppressor and Oncogene
por: Bazzi, Zainab A., et al.
Publicado: (2021)

Prognostic Factors and Scoring Model for Survival in Metastatic Biliary Tract Cancer
por: Park, Hyung Soon, et al.
Publicado: (2017)

Toripalimab in advanced biliary tract cancer
por: Li, Wei, et al.
Publicado: (2022)

Dysbiosis of the Fecal and Biliary Microbiota in Biliary Tract Cancer
por: Ito, Zensho, et al.
Publicado: (2022)

The Wnt Antagonist sFRP1 as a Favorable Prognosticator in Human Biliary Tract Carcinoma
por: Kang, Pengcheng, et al.
Publicado: (2014)

Transcatheter arterial chemoembolization with gemcitabine and oxaliplatin for the treatment of advanced biliary tract cancer
por: Zhao, Qing, et al.
Publicado: (2015)

Survival rates are higher in married patients with biliary tract cancer: a population-based study
por: Song, Wei, et al.
Publicado: (2018)

Clinical and biomarker analyses of sintilimab plus gemcitabine and cisplatin as first-line treatment for patients with advanced biliary tract cancer
por: Zeng, Tian-mei, et al.
Publicado: (2023)

Association Between Aspirin Use and Biliary Tract Cancer Survival
por: Jackson, Sarah S., et al.
Publicado: (2019)

Comprehensive analysis of coagulation indices for predicting survival in patients with biliary tract cancer
por: Ke, Xindi, et al.
Publicado: (2021)

Low Expression of CDK10 Correlates with Adverse Prognosis in Gastric Carcinoma
por: Zhao, Bai-wei, et al.
Publicado: (2017)

Genomics driven precision oncology in advanced biliary tract cancer improves survival
por: Kumar-Sinha, Chandan, et al.
Publicado: (2023)

Rapid screening for Chlamydia trachomatis infection by detecting α-mannosidase activity in urogenital tract specimens
por: Wang, Ze-yu, et al.
Publicado: (2013)

BILIARY TRACT DISORDERS
Publicado: (1984)

Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancers
por: Zheng, Kanglian, et al.
Publicado: (2022)

Percutaneous transhepatic and endoscopic biliary drainage for malignant biliary tract obstruction: a meta-analysis
por: Leng, Jian-jun, et al.
Publicado: (2014)

An Assessment of Combination of the Camrelizumab With Chemotherapy in Metastatic Biliary Tract Cancers
por: Yu, Yi, et al.
Publicado: (2021)

Direct repression of the oncogene CDK4 by the tumor suppressor miR-486-5p in non-small cell lung cancer
por: Shao, Yang, et al.
Publicado: (2016)

Preoperative biliary drainage for biliary tract and ampullary carcinomas
por: Nagino, Masato, et al.
Publicado: (2008)

Safety Evaluation of Paclitaxel-Eluting Biliary Metal Stent with Sodium Caprate in Porcine Biliary Tract
por: Jang, Sung Ill, et al.
Publicado: (2019)

Neoadjuvant Therapy for Extrahepatic Biliary Tract Cancer: A Propensity Score-Matched Survival Analysis
por: Toyoda, Junya, et al.
Publicado: (2023)

Insulin therapy and biliary tract cancer: insights from real-world data
por: Qi, Xiaohui, et al.
Publicado: (2022)

The impact of skeletal muscle mass on survival outcome in biliary tract cancer patients
por: Limpawattana, Panita, et al.
Publicado: (2018)

Impact of preoperative body compositions on survival following resection of biliary tract cancer
por: Yoon, Seung Bae, et al.
Publicado: (2019)

Interleukin-6 induces epithelial-mesenchymal transition in human intrahepatic biliary epithelial cells
por: JIANG, GUI-XING, et al.
Publicado: (2016)

Diseases of the liver and biliary tract /
Publicado: (1992)

Viral Infections of the Biliary Tract
por: Gupta, Ekta, et al.
Publicado: (2008)

Streptomycin in Biliary Tract Infection
por: Chaudhuri, R. N., et al.
Publicado: (1950)

Diseases of the Liver and Biliary Tract
por: Johnson, Susan E., et al.
Publicado: (2006)

Updates in Biliary Tract Cancers
por: Li, Daneng, et al.
Publicado: (2022)

Immunobiology of the biliary tract system
por: Björkström, Niklas K.
Publicado: (2022)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

Therapeutic Targeting of CDK7 Suppresses Tumor Progression in Intrahepatic Cholangiocarcinoma
por: Chen, Hua-Dong, et al.
Publicado: (2020)

CDK5 is a major regulator of the tumor suppressor DLC1
por: Tripathi, Brajendra K., et al.
Publicado: (2014)

Therapeutic Effect and Prognosis of Biliary Tract Tumor Transformation
por: Shang, PeiPei, et al.
Publicado: (2022)

Systemic treatment options for advanced biliary tract carcinoma
por: Xie, Changqing, et al.
Publicado: (2020)

Abnormal Anatomical Variations of Extra-Hepatic Biliary Tract, and Their Relation to Biliary Tract Injuries and Stones Formation
por: Khayat, Meiaad F., et al.
Publicado: (2014)

Effect of midkine on gemcitabine resistance in biliary tract cancer
por: Lu, Yongliang, et al.
Publicado: (2018)

Combined Intestinal and Biliary Stenting in Gastric Outlet and Biliary Obstruction
por: Wang, Guang Chuan, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_msr2a8tdn66g2v4mf2ipu6fudn